Immunohistochemistry (IHC) Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities

The Immunohistochemistry (IHC) Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Immunohistochemistry (IHC) Market Size and Projected Growth Rate?
The market size of immunohistochemistry (IHC) has seen robust growth in the past few years. Its size is projected to grow from $2.58 billion in 2024 to $2.78 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.0%. Factors contributing to this growth during the historic period include its adoption in clinics, standardization within the industry, growth in cancer research, laboratory automation, and advancements in clinical diagnostics.

The market size for immunohistochemistry (IHC) is anticipated to experience a swift surge in the coming years, reaching a value of $4.13 billion by 2029 with a compound annual growth rate (CAGR) of 10.4%. The predicted expansion during the forecast period is due to the entry of new market players, demand for drug creation, the inclusion of biomedical research, diagnostic usage, automation and digital transformation. Key trends during the forecast window are expected to be the use of multiplex IHC methods, the integration of digital pathology, improvements in antibody specificity, automation and standardization, with applications in the area of biomarker discovery.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9267

What Are the Different Immunohistochemistry (IHC) Market Segments?
The immunohistochemistry (IHC) market covered in this report is segmented -

1) By Product: Antibodies, Equipment, Reagents, Kits
2) By Applications: Diagnostics, Drug Testing, Other Applications
3) By End-Users: Hospitals And Diagnostic Laboratories, Research Institutes, Other End-Users

Subsegments:
1) By Antibodies: Primary Antibodies, Secondary Antibodies, Conjugated Antibodies
2) By Equipment: IHC Staining Systems, Tissue Processors, Slide Scanners, Microscopes
3) By Reagents: Detection Reagents, Blocking Reagents, Mounting Media
4) By Kits: Pre-prepared IHC Kits, Multiplex IHC Kits, Specialty Kits

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9267&type=smp

What Are the Primary Drivers Shaping the Immunohistochemistry (IHC) Market?
The surge in chronic disease incidents is anticipated to drive the progression of the immunohistochemistry (IHC) market. Chronic ailments are defined as health conditions that persist for three months or more and can generally be managed but not completely cured. The diagnosis of chronic diseases such as cancer, cardiovascular disorders, and others is facilitated by immunohistochemistry due to its various merits such as specificity, sensitivity (utilized for the detection of specific antigens), swift outcomes, and more. For example, in 2022, the Centers for Disease Control and Prevention, a national health organization based in the US, recorded approximately 37.3 million people with diabetes, corresponding to 11.3% of the entire US population. Consequently, the escalating prevalence of chronic ailments is triggering the expansion of the immunohistochemistry (IHC) market.

Which Companies Are Leading in the Immunohistochemistry (IHC) Market?
Major companies operating in the immunohistochemistry (IHC) market include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, The Merck Group, Danaher Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB Inc., Agilent Technologies Inc., Abcam plc, Becton Dickinson and Company, Takara Bio Inc., Biocare Medical LLC, Bio-Genex Laboratories, Diagnostic BioSystems Inc., BioVision Inc., PHC Holdings Corporation, Abbott Laboratories, Leica Biosystems, Vector Laboratories, Indivumed GmbH, Qritive, Ionpath Inc., Reveal Biosciences, Akrivis Technologies Private Limited, LifeSpan BioSciences Inc., Enzo Life Sciences Inc., Epitomics Inc., GenScript Biotech, Histologix Ltd., NeoGenomics Laboratories Inc.

What Are the Major Trends Shaping the Immunohistochemistry (IHC) Market?
Major firms in the immunohistochemistry (IHC) market are striving to improve diagnostic accuracy through the use of pioneering technologies and superior quality reagents to bolster the efficacy of tissue analysis across multiple clinical and research applications. The Neoflex multiomics mass spectrometry imaging (MSI) system plays a crucial role as a state-of-the-art imaging platform designed specifically for detailed tissue analysis. This facilitates researchers' shift from the discovery phase to clinical applications via precise mass spectrometry techniques, specifically for the spatial mapping of biomolecules in tissues. For example, in June 2024, Bruker Corporation, an American firm that specializes in the production and provision of scientific tools as well as analytical and diagnostic solutions, introduced their matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF/TOF) Neoflex Imaging Profiler for tissue imaging based on mass spectrometry. The Neoflex multiomics mass spectrometry imaging (MSI) system caters to the demand for transitioning from discovery imaging to clinical tissue investigation. It boasts of Bruker's 10-kHz smartbeam 3D laser, superior imaging detectors, and is compatible with OME-TIFF file output using SCiLS Scope software.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/immunohistochemistry-ihc-global-market-report

What Are the Top Revenue-Generating Geographies in the Immunohistochemistry (IHC) Market?
North America was the largest region in the immunohistochemistry (IHC) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the immunohistochemistry (IHC) market report during the forecast period. The regions covered in the immunohistochemistry (IHC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Immunohistochemistry (IHC) Market?
2. What is the CAGR expected in the Immunohistochemistry (IHC) Market?
3. What Are the Key Innovations Transforming the Immunohistochemistry (IHC) Industry?
4. Which Region Is Leading the Immunohistochemistry (IHC) Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.